middle.news
OncoSil Medical Gains Saudi FDA Approval Unlocking Full Reimbursement Access
8:31am on Monday 20th of July, 2026 AEST
•
Healthcare
Read Story
OncoSil Medical Gains Saudi FDA Approval Unlocking Full Reimbursement Access
8:31am on Monday 20th of July, 2026 AEST
Key Points
Saudi FDA approval grants full reimbursement for OncoSil™ device
Access opens Saudi Arabia as regional cancer treatment hub
Partnership with Abdulla Fouad Group key to regulatory success
OncoSil™ already approved in 30+ countries including EU and Australia
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Oncosil Medical (ASX:OSL)
OPEN ARTICLE